This academic paper describes bridge clinics, which offer immediate, low barrier access to medications for opioid use disorder and other substance use disorder treatment, helping to close gaps in the continuum of care. It reviews available evidence for bridge clinic effectiveness in care delivery, including retention in treatment, while highlighting gaps in data on their effectiveness.

This database from the CDC allows users to examine prevalence of fatal overdoses for 28 states and the District of Columbia in 2020. Comprehensive information on decedents is given beyond what is available on a death certificate.  

This report describes the current distribution and funding mix for naloxone access and explores the potential impacts of policy changes to expand coverage for naloxone as a non-prescription product. It argues that non-prescription status for naloxone and education about its efficacy and availability would help reduce opioid overdose deaths in the US.

This academic paper outlines a study which investigated the impact of supervised injection facilities on individuals who use injected drugs. The authors implemented a systematic review of existing studies on this specific topic and concluded that supervised injection facilities reduce the risk of overdose morbidity and mortality and improve access to care. 

This is a report from the National Council on Mental Wellbeing that aims to help harm reduction organizations, treatment providers, and other organizations that serve people who use drugs overcome challenges associated with implementing telehealth and technology-assisted services and leverage these advances to help improve the health and wellness of the individuals they serve. Successful initiatives are highlighted throughout the report. 

A webpage by the Harm Reduction Coalition with documents, curriculum trainings, and other resources for building alliances with law enforcement to support syringe exchanges.  

This is the abstract of a peer-reviewed article about the implementation of evidence-based opioid interventions in the face of opposition. This paper uses the experience of the first syringe exchange in North Carolina, which is considered the first program of its kind in a red state.

This is an issue brief from the Baker Institute for Public Policy, written to influence policymakers in Texas, that gives an overview of the evidence for syringe service programs (SSP) and provides case studies of different states that have implemented SSPs. 

These are slides from a webinar by the Office of the Assistant Secretary for Health that gives an overview of implementation, sustainability, and funding for syringe services programs (SSP). The experiences of Kentucky, North Carolina, and New Mexico with SSPs are discussed in detail.

This is a report from the National Alliance of State & Territorial AIDS Directors (NASTAD) that provides guidelines to assist state and local health department jurisdictions that want to implement or expand existing syringe service programs and link injection drug users to vital prevention, medical, and social services.

This is an academic paper that provides commentary an overview of operational changes for 82 syringe service programs SSP) across the United States as a result of the coronavirus pandemic. Most SSPs remained open (85%) but services were disrupted as some offered less services and others had moved to mobile outreach. 

These are the slides from a webinar by several federal organizations, including the CDC, HRSA, and the Office of the Assistant Secretary for Health, that discuss the importance of syringe service programs (SSP) as a public health intervention to address the opioid crisis. An overview of evidence, funding, and examples of comprehensive SSPs are provided.